Discussing Regulatory Affairs Leadership Perspectives – 2024 Survey Insights

Join the discussion to hear from industry leaders sharing key insights and learnings from the recent survey conducted across the life sciences industry from Celegence in partnership with RAPS which had nearly 700 participants. This is a thought-provoking session exploring the findings and insights on topics such as top challenges and opportunities, planned investments near and long term, and alignment to changing technology such as real AI/Artificial Intelligence use cases. The speakers will look at specifics in pharma such as efficiency in publications and submission including eCTD v4.0 (electronic common technical document), lean authoring, readiness for IDMP (identification of medicinal products), and evolving practices in medical writing. On medical devices, the session will cover specifics such as MDR/IVDR remediation and maintenance, QMS, and technical file management.

Don’t miss this opportunity to enhance your regulatory skills and understanding.